Objective: To address high-frequency failure modes such as medication incompatibility errors in the outpatient and emergency intravenous infusion process, an FMEA-based standardized process system was developed for proactive prevention and control. Methods: 400 patients were randomly divided into two groups. The observation group implemented a 12-step FMEA-driven process with closed-loop mechanisms, while the control group followed traditional procedures. Results: The observation group demonstrated significant reductions in failure frequency and risk priority numbers, with the relative risk of error incidence decreasing to 0.10–0.27. Procedure time was shortened by 17.6%, and high-risk step identification rates achieved high levels. Conclusion: This process effectively reduces medical risks, enables a paradigm shift in preventive strategies, and holds clinical promotion value.
Jing et al. (Wed,) studied this question.